200 mg GILEAD (Emtriva 200 mg)
Generic Name: emtricitabine
Pill imprint 200 mg GILEAD has been identified as Emtriva 200 mg.
Emtriva is used in the treatment of nonoccupational exposure; hiv infection; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Emtriva 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- emtricitabine
- Imprint:
- 200 mg GILEAD
- Strength:
- 200 mg
- Color:
- Blue & White
- Size:
- 19.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Gilead Sciences
- National Drug Code (NDC):
- 61958-0601
- Inactive Ingredients:
- microcrystalline cellulose
crospovidone
povidone
magnesium stearate
water
FD&C Blue No. 2
titanium dioxide
gelatin
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4853 | Physicians Total Care Inc (repackager) |
| 54569-5521 | A-S Medication Solutions, LLC (repackager) |
| 35356-0205 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More about Emtriva (emtricitabine)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
